New York, NY -- (SBWIRE) -- 12/27/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), Healthcare Trust Of America Inc (NYSE:HTA), Generex Biotechnology Corporation (OTCMKTS:GNBT), Miller Energy Resources Inc (NYSE:MILL)
Peregrine Pharmaceuticals (NASDAQ:PPHM) showed a volume of 1.03 million shares by the end of last trade whereas the average volume of the stock remained 1.08 million shares. The stock opened the session at $1.37 but then moved to $1.37. At that price, the stock showed a negative performance of -1.44%. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies. Bavituximab is the Company's therapeutic PS-targeting antibody, which has demonstrated therapeutic potential and represents a new approach to treating cancer. PGN650 is the Company's PS-targeting imaging agent that represents a potential new approach to imaging cancer.
Will PPHM Get Buyers Even After The Recent Rally? Find Out Here
Healthcare Trust Of America Inc (NYSE:HTA) opened the session at $9.86 and closed the session at $9.92. The stock showed a negative performance of -0.10% in previous trading session. Healthcare Trust of America, Inc. is a self-administered real estate investment trust (REIT). The Company’s primary business consists of acquiring, owning and operating its portfolio of medical office buildings and other healthcare-related facilities. Its portfolio is primarily concentrated within the United States metropolitan areas and located primarily on or adjacent to (within a 0.25 mile) the campuses of healthcare systems.
Has HTA Found The Bottom And Ready To Gain Momentum? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) opened the session at $0.03 and closed the session at $0.00290. The stock showed a positive/ performance of 1.75% in previous trading session. Traded with volume of 1.03 million shares in the prior session and the average volume of the stock remained 1.89 million shares. The beta of the stock remained 2.13. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world.
Why Should Investors Buy GNBT After The Recent Gain? Just Go Here and Find Out
Miller Energy Resources Inc (NYSE:MILL) the stock decreased -5.10% and finished the session at $6.88. Traded with volume of 1.02 million shares in the prior session and the average volume of the stock remained 1.04 million shares. The beta of the stock remained 3.95. Miller Energy Resources, Inc. is an independent exploration and production company that utilizes seismic data and other technologies for geophysical exploration and development of oil and gas wells in the Appalachian region of East Tennessee and in southcentral Alaska. The Company offers these services, on a contract basis, to third-party customers primarily engaged in natural gas exploration and production.
Will MILL Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)